GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
54.23
+0.39 (0.72%)
At close: Mar 30, 2026, 4:00 PM EDT
54.94
+0.71 (1.31%)
Pre-market: Mar 31, 2026, 7:36 AM EDT
GSK Revenue
In the year 2025, GSK had annual revenue of 32.67B GBP with 4.11% growth. GSK had revenue of 8.62B in the quarter ending December 31, 2025, with 6.17% growth.
Revenue (ttm)
32.67B GBP
Revenue Growth
+4.11%
P/S Ratio
2.47
Revenue / Employee
488,727 GBP
Employees
66,841
Market Cap
108.78B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.67B | 1.29B | 4.11% |
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | 33.75B | 2.93B | 9.52% |
| Dec 31, 2018 | 30.82B | 635.00M | 2.10% |
| Dec 31, 2017 | 30.19B | 2.30B | 8.24% |
| Dec 31, 2016 | 27.89B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck & Co. | 65.01B |
| Pfizer | 62.58B |
| AbbVie | 61.16B |
| AstraZeneca | 58.74B |
| Novartis AG | 56.67B |
| Sanofi | 54.85B |
| Novo Nordisk | 48.59B |
| Bristol-Myers Squibb Company | 48.19B |
GSK News
- 13 hours ago - GSK Achieves Approval in China for Asthma Treatment Exdensur - GuruFocus
- 13 hours ago - GSK (GSK) Seeks Chinese Approval for New Hepatitis B Treatment - GuruFocus
- 21 hours ago - Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks. - Barrons
- 1 day ago - GSK Announces Approval For Exdensur In China - Nasdaq
- 4 days ago - GSK: European Medicines Agency To Review MAA For Bepirovirsen - Nasdaq
- 4 days ago - GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript - Seeking Alpha
- 5 days ago - GSK PLC (GSK) Stock Price Up 3.7% on Mar 25 - GuruFocus
- 6 days ago - Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV Re-Vaccination In Older Adults - Nasdaq